Infection and Immunity · 1991 · 58 citations · 17 references
Veterinary MedicineImmunologyInfectious DiseasesHost-pathogen InteractionsImmunology Of Infectious DiseasesInnate ImmunityCytokine BiologyHost-parasite Immune InteractionsInnate Immunity To ParasitesInterferon ResponsesMacrophage BiologyMacrophage Responses To ParasitesInterferon ProductionInterferon-mediated Innate ImmunityMacrophage Activation By ProtozoaMacrophage Interferon ResponsesMonocyte-derived MacrophagesPeritoneal MacrophagesToxoplasmosis PathogenesisToxoplasmosis Treatment
The role of recombinant murine beta interferon (rMuIFN-beta) and recombinant human IFN-beta (rHuIFN-beta) in resistance to Toxoplasma gondii was examined. rMuIFN-beta protected mice against a lethal infection with the parasite. The protective effect appeared to depend on the concomitant release of gamma interferon. rMuIFN-beta did not activate murine peritoneal macrophages to inhibit or kill T. gondii whether used alone or in combination with lipopolysaccharide (LPS). rHuIFN-beta did not activate human monocyte-derived macrophages to inhibit or kill T. gondii when 5-day-old monocyte-derived macrophages were used. In contrast, significant killing of T. gondii was noted when 10-day-old monocyte-derived macrophages were used. The addition of LPS enhanced this effect. These results revealed a role for IFN-beta in the mechanisms of defense against T. gondii and suggest its potential use in the treatment of toxoplasmosis in humans.
17
Interferon-γ: the Major Mediator of Resistance Against <i>Toxoplasma gondii</i>
Yasuhiro Suzuki, Manuel Orellana, Robert D. Schreiber et al. · Science · 1988 · 1.2K citations
Christopher B. Wilson, Vicky Wang-Wei Tsai, Jack S. Remington · The Journal of Experimental Medicine · 1980 · 318 citations · Full text
Life Sciences, Immunology, Pathology +14